Chronic Pain and Opioid Use Disorder Increase Suicide Risk
Researchers evaluated the suicide risk for patients with chronic non-cancer pain and a co-occurring opioid use disorder.
Diagnosis & Disease Information
Association Between Opioid Prescribing and US Suicide Trends
A retrospective study of several US national databases evaluated the association between regional reductions in opioid prescribing with a reduction in total suicide deaths and opioid-specific suicide overdose deaths.
Evidence for Safety, Efficacy of Analgesics for Acute Low Back Pain Is Limited
Researchers sought to evaluate the comparative effectiveness and safety of analgesics for acute low back pain.
Hospitalization Linked With Substance Use and Psychiatric Disorders in COVID-19
Investigators sought to evaluate the association of comorbid PD and SUD with the probability of hospitalization among patients with COVID-19 in the emergency department.
Are Low-Dose Opioids Safe and Effective for Refractory Restless Leg Syndrome?
Researchers sought to investigate symptom control with low-dose opioids in patients with refractory RLS.
Why Is Methadone So Hard to Prescribe for Opioid Use Disorder?
Jim Anderson, MPAS, PA-C, wonders if SAMHSA will make the methadone take-home flexibility program permanent.
DEA: “Rainbow Fentanyl” a Deliberate Tactic to Target Young People
Brightly colored versions of the synthetic opioid fentanyl are appearing across the US, according to the Drug Enforcement Administration (DEA). In a press statement, the Agency reported that the colorful fentanyl, dubbed “rainbow fentanyl”, has been seized in 18 different states and has been found in multiple forms, including pills, powder, and blocks that resemble…
Opioid Denials Lead to Rise in Violent Attacks on Pain and Addiction Experts
Pain and addiction specialists discuss the rise in workplace violence related to opioid denials and how to improve communication and change patient expectations.
Expert Panel Sees Challenges With Federally Mandated Opioid Prescriber Education
During the workshop, speakers and panelists reviewed past programs that were put into place to reduce opioid prescribing, as well as trends in opioid prescribing and overdose deaths.
Once-Weekly Levomethadone Fast Tracked for Opioid Use Disorder
LYN-014 is an investigational oral, once-weekly, ultra-long-acting, extended-release levomethadone capsule to treat opioid use disorder.
- Loading...
Loading...
Loading... 
Loading...